An interventional study of Dietary education(nutritional counselling) in Gastric Cancer and Gastrectomy, sponsored by Samsung Medical Center. Recruiting at 1 site in Korea, Republic of. Open to participants aged 20 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-07-15.
Sponsored by Samsung Medical Center · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 40 studies in Stomach Neoplasms by Samsung Medical Center — 6 open to participants now, 7 under way, none of them phase 3. Stomach Neoplasms · Samsung Medical Center.
Among the 40 studies in Stomach Neoplasms by Samsung Medical Center, this one is the 4th largest by planned enrollment of the 32 interventional ones that give a count, is one of 3 that started in 2021, is one of 6 with no phase, and was the 33rd registered.
3,406 studies on the registry are indexed under Stomach Neoplasms; 994 are open to participants now.
Browse Stomach Neoplasms studies →6 of the 40 studies in Stomach Neoplasms by Samsung Medical Center are open now, in 1 country. Recruiting first, the newest first:
Samsung Medical Center · Sites in Korea, Republic of
Ages 20+
Samsung Medical Center · Sites in Korea, Republic of
Ages 19+
Samsung Medical Center · Sites in Korea, Republic of
Ages 20+
Samsung Medical Center · Sites in Korea, Republic of
Healthy volunteers
Samsung Medical Center · Sites in Korea, Republic of
Ages 19–100
By country, each count listing its studies:
Of the 704 Stomach Neoplasms studies recruiting now, 375 (53%) set no upper age limit and 194 (28%) stop at 75 or younger; 27 take children under 18; 70 take healthy volunteers.
This study: 20 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
40 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 16 · Phase 3 8
First in 2003; this study’s year is marked. 3 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 358 is above the median of 66 across 2,505 interventional studies indexed under Stomach Neoplasms.
Median enrollment 66 across the 32 interventional studies, 375 across the 8 observational. Of the 24 that completed or were terminated, 1 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
Samsung Medical Center is the lead sponsor of 1,013 studies on the registry; 153 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 40 studies in Stomach Neoplasms by Samsung Medical Center, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Radical gastrectomy has been known as the most effective treatment of curable gastric cancer.However, there is a high risk of malnutrition and weight loss after a gastrectomy which may be attributed to inadequate oral consumption, malabsorption and loss of the reservoir function of the stomach.Weight loss has been regarded as an independent risk factor for postoperative mortality and morbidity and It is also closely associated with a quality of life after surgery. No specific surgical technique has been proved to be effective in reducing postoperative weight loss and it seems like that dietary education and consultation is the best way to minimize weight loss in gastrectomy patients in clinical setting. In this regard, the investigators performed a retrospective pilot study to identify the effect of routinely performed (simplified) dietary education on nutritional status after gastrectomy, but it revealed that the effect of simplified dietary education on weight loss was not clear and the result implies that more intensive dietary education may be necessary after gastrectomy. The aim of this randomized controlled trial (RCT) is to elucidate the effect of intensive dietary education on nutritional status after gastrectomy in comparison with simplified dietary education.
Subject 1: subtotal gastrectomy group
subject 2: total gastrectomy group
Objectives:
Primary objective: to evaluate Weight loss difference of simplified dietary education(SE) versus intensive dietary education(IE) for patients after undergoing a gastrectomy
Primary endpoint: Superiority of weight loss difference (%) of IE group between post op 1mo and 12mo
Secondary objectives:
weight loss(%) of each subgroup, nutritional parameters (PG-SGA), Calrorie intake \& dietary habits, albumin, hemoglobin, iron panel (TIBC, ferritin), Absolute lymphocyte count(ALC), vit B12, homocysteine, quality of life(QOL) change
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
adequate organ functions defined as indicated below:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).
Your pathology report is the document that shows this.
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.
Two enzymes measured in a routine blood test of the liver. Higher levels can mean the liver is under strain or damaged. SGPT and SGOT are older names for ALT and AST.
Criteria usually give a limit as a multiple of the upper limit of normal (ULN), often higher when cancer has spread to the liver.
A yellow substance made when red blood cells are broken down, which the liver clears. A high level can mean a problem with the liver or the bile ducts.
Criteria often allow more for people with Gilbert’s syndrome, a harmless inherited condition that raises bilirubin.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Histologically or cytologically confirmed
The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).
Your pathology report is the document that shows this.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Metastases
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hemoglobin (Hb)
The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Platelets
Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ALT and AST (liver enzymes)
Two enzymes measured in a routine blood test of the liver. Higher levels can mean the liver is under strain or damaged. SGPT and SGOT are older names for ALT and AST.
Criteria usually give a limit as a multiple of the upper limit of normal (ULN), often higher when cancer has spread to the liver.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Bilirubin
A yellow substance made when red blood cells are broken down, which the liver clears. A high level can mean a problem with the liver or the bile ducts.
Criteria often allow more for people with Gilbert’s syndrome, a harmless inherited condition that raises bilirubin.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
simplified dietary education arm in subtotal gastrectomy group.
Other: Dietary education(nutritional counselling)
intensive dietary education arm in subtotal gastrectomy group
Other: Dietary education(nutritional counselling)
simplified dietary education arm in total gastrectomy group.
Other: Dietary education(nutritional counselling)
intensive dietary education arm in total gastrectomy group
Other: Dietary education(nutritional counselling)
Dietary education provided to gastrectomy patients by dietitian.
Change from preoperative weight change at immediate postoperative period in SE and IE groups.
comparison of weight change between the two groups after surgery
Time frame: preoperative, immediate postoperative
Change from preoperative weight change at postoperaive 1 month in SE and IE groups.
comparison of weight change between the two groups after surgery
Time frame: preoperative, postoperative 1 month
Change from preoperative weight change at postoperaive 3 months in SE and IE groups.
comparison of weight change between the two groups after surgery
Time frame: preoperative, postoperative 3 months
Change from preoperative weight change at postoperaive 6 months in SE and IE groups.
comparison of weight change between the two groups after surgery
Time frame: preoperative, postoperative 6 months
Change from preoperative weight change at postoperaive 12 months in SE and IE groups.
comparison of weight change between the two groups after surgery
Time frame: preoperative, postoperative 12 months
Change from preoperative weight change at postoperaive 18 months in SE and IE groups.
comparison of weight change between the two groups after surgery
Time frame: preoperative, postoperative 18 months
Nutritional parameters
measured by Patient-Generated Subjective Global Assessment (PG-SGA; rating A,B,C)
Time frame: preoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months
24hrs dietary recall
calculating kcal \& protein intake by 24hrs dietary recall (questionnaire)
Time frame: preoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months
dietary habits
number of meals, eating speed (questionnaire)
Time frame: preoperative, immediate postoperative, postoperative 1 months, 3 months, 6months, 12 months, 18 months
Albumin
g/dL
Time frame: preoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months
Hemoglobin
g/dL
Time frame: preoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months
Total iron binding capacity (TIBC)
μg/dL
Time frame: preoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months
Ferritin
ng/mL
Time frame: preoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months
Absolute lymphocyte count (ALC)
10\^3/μL
Time frame: preoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months
Vitamin B12
pg/mL
Time frame: preoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months
Homocysteine
μmol/L
Time frame: preoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months
Quality of life of the patients
European quality of life questionnaire (EQ-5D); the descriptive system which comprises 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, extreme problems (labelled 1-3).
Time frame: preoperative, immediate postoperative, postoperative 1 month, 3 months, 6months, 12 months, 18 months
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Started Mar 2021 (actual). Primary completion is estimated for Oct 2024, 43 months after the start.
Of 358 non-industry interventional studies with no phase under Stomach Neoplasms, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 63. This study's planned 43 months is above that.
Counting every sponsor, half of 369 studies reached it within 36 months; a quarter within 17 and three quarters within 63.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.